Overview

Safety Study of Nebulized RNS60 to Treat Asthma.

Status:
Completed

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is two-fold. First, to determine whether nebulized RNS60 is safe in healthy human subjects and in subjects with mild asthma, in a single-dose administration. Second, to determine whether nebulized RNS60 is safe in human subjects with mild-to-moderate asthma over a 4-week period.

Phase:

Phase 1

Details

Lead Sponsor:

Revalesio Corporation

Treatments:

RNS60